A recent report suggested that proteins regulating GHSR1a function represented a potentially exciting new therapeutic target to treat appetite dysfunction, Alzheimer’s disease, insulin deficiency, and chronic inflammation (51). This evidence concerns the gene GHSR and early-onset autosomal dominant Alzheimer disease.